참고문헌 (40)

1. Pediatr Cardiol A Desai 26 627 2005 10.1007/s00246-004-0864-5 Desai A, Patel S, Book W. “Myocardial infarction” in adolescents: do we have the correct diagnosis? Pediatr Cardiol 2005;26:627-31. doi: 10.1007/s00246-004-0864-5 . 

   상세보기

2. Pediatr Infect Dis J JC Burns 21 993 2002 10.1097/00006454-200211000-00002 Burns JC. Commentary: translation of Dr. Tomisaku Kawasaki’s original report of fifty patients in 1967. Pediatr Infect Dis J 2002;21:993-5. doi: 10.1097/00006454-200211000-00002 . 

   상세보기

3. Int J Infect Dis D Burgner 9 185 2005 10.1016/j.ijid.2005.03.002 Burgner D, Harnden A. Kawasaki disease: what is the epidemiology telling us about the etiology? Int J Infect Dis 2005;9:185-94. doi: 10.1016/j.ijid.2005.03.002 . 

   상세보기

4. J Hum Genet Y Onouchi 52 179 2007 10.1007/s10038-006-0092-3 Onouchi Y, Tamari M, Takahashi A, Tsunoda T, Yashiro M, Nakamura Y, et al. A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12. J Hum Genet 2007;52:179-90. doi: 10.1007/s10038-006-0092-3 . 

   상세보기

5. Pediatrics JW Newburger 114 1708 2004 10.1542/peds.2004-2182 Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33. doi: 10.1542/peds.2004-2182 . 

   상세보기

6. Clin Exp Immunol M Biezeveld 147 106 2007 10.1111/j.1365-2249.2006.03266.x Biezeveld M, Geissler J, Merkus M, Kuipers IM, Ottenkamp J, Kuijpers T. The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease. Clin Exp Immunol 2007;147:106-11. 

   상세보기

7. J Korean Med Sci YH Shim 21 208 2006 10.3346/jkms.2006.21.2.208 Shim YH, Kim HS, Sohn S, Hong YM. Insertion/deletion polymorphism of angiotensin converting enzyme gene in Kawasaki disease. J Korean Med Sci 2006;21:208-11. 

   상세보기

8. J Pediatr T Minami 147 78 2005 10.1016/j.jpeds.2005.03.037 Minami T, Suzuki H, Takeuchi T, Uemura S, Sugatani J, Yoshikawa N. A polymorphism in plasma platelet-activating factor acetylhydrolase is involved in resistance to immunoglobulin treatment in Kawasaki disease. J Pediatr 2005;147:78-83. doi: 10.1016/j.jpeds.2005.03.037 . 

   상세보기

9. Hum Immunol FY Huang 68 69 2007 10.1016/j.humimm.2006.10.018 Huang FY, Chang TY, Chen MR, Hsu CH, Lee HC, Lin SP, et al. Genetic variations of HLA-DRB1 and susceptibility to Kawasaki disease in Taiwanese children. Hum Immunol 2007;68:69-74. doi: 10.1016/j.humimm.2006.10.018 . 

   상세보기

10. Pediatr Res HS Jin 61 584 2007 10.1203/pdr.0b013e3180459fb5 Jin HS, Kim HB, Kim BS, Lee JK, Seo EJ, Yoo HW, et al. The IL-10 (-627 A/C) promoter polymorphism may be associated with coronary aneurysms and low serum albumin in Korean children with Kawasaki disease. Pediatr Res 2007;61:584-7. 

    상세보기

11. Immunity A Zlotnik 12 121 2000 10.1016/S1074-7613(00)80165-X Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000;12:121-7. doi: 10.1016/S1074-7613(00)80165-X . 

    상세보기

12. Immunology C Desmetz 119 551 2006 10.1111/j.1365-2567.2006.02470.x Desmetz C, Lin YL, Mettling C, Portales P, Rabesandeatana H, Clot J, et al. The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density. Immunology 2006;119:551-61. doi: 10.1111/j.1365-2567.2006.02470.x . 

    상세보기

13. J Infect Dis JC Burns 192 344 2005 10.1086/430953 Burns JC, Shimizu C, Gonzalez E, Kulkarni H, Patel S, Shike H, et al. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J Infect Dis 2005;192:344-9. doi: 10.1086/430953 . 

    상세보기

14. Research Committee on Kawasaki Disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. 1984.Tokyo, Japan: Ministry of Health and Welfare. 

15. Curr Opin Rheumatol F Falcini 18 33 2006 10.1097/01.bor.0000197998.50450.f6 Falcini F. Kawasaki disease. Curr Opin Rheumatol 2006;18:33-8. doi: 10.1097/01.bor.0000197998.50450.f6 . 

    상세보기

16. J Infect Dis SR Dominguez 194 1697 2006 10.1086/509509 Dominguez SR, Anderson MS, Glodé MP, Robinson CC, Holmes KV. Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome. J Infect Dis 2006;194:1697-701. doi: 10.1086/509509 . 

    상세보기

17. Yonsei Med J SY Ahn 44 1021 2003 10.3349/ymj.2003.44.6.1021 Ahn SY, Jang GC, Shin JS, Shin KM, Kim DS. Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Med J 2003;44:1021-6. 

    상세보기

18. Arthritis Rheum LR Wedderburn 43 765 2000 10.1002/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B Wedderburn LR, Robinson N, Patel A, Varsani H, Woo P. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum 2000;43:765-74. doi: 10.1002/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B . 

    상세보기

19. Int Immunol N Suzuki 11 553 1999 10.1093/intimm/11.4.553 Suzuki N, Nakajima A, Yoshino S, Matsushima K, Yagita H, Okumura K. Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol 1999;11:553-9. doi: 10.1093/intimm/11.4.553 . 

    상세보기

20. J Clin Invest TL Sorensen 103 807 1999 10.1172/JCI5150 Sorensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 1999;103:807-15. doi: 10.1172/JCI5150 . 

    상세보기

21. J Clin Invest S Qin 101 746 1998 10.1172/JCI1422 Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998;101:746-54. doi: 10.1172/JCI1422 . 

    상세보기

22. Arthritis Rheum M Mack 42 981 1999 10.1002/1529-0131(199905)42:5<981::AID-ANR17>3.0.CO;2-4 Mack M, Bruhl H, Gruber R, Jaeger C, Cihak J, Eiter V, et al. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. Arthritis Rheum 1999;42:981-8. doi: 10.1002/1529-0131(199905)42:5<981::AID-ANR17>3.0.CO;2-4 . 

    상세보기

23. Proc Natl Acad Sci U S A KE Balashov 96 6873 1999 10.1073/pnas.96.12.6873 Balashov KE, Rottman JB, Weiner HL, Hancock WW. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1 alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A 1999;96:6873-8. doi: 10.1073/pnas.96.12.6873 . 

    상세보기

24. Biochemistry M Samson 35 3362 1996 10.1021/bi952950g Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 1996;35:3362-7. doi: 10.1021/bi952950g . 

    상세보기

25. Circulation H Kato 94 1379 1996 10.1161/01.CIR.94.6.1379 Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R. Long-term consequences of Kawasaki disease A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-85. 

    상세보기

26. J Pediatr G Koren 108 388 1986 10.1016/S0022-3476(86)80878-2 Koren G, Lavi S, Rose V, Rowe R. Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 1986;108:388-92. doi: 10.1016/S0022-3476(86)80878-2 . 

    상세보기

27. Am J Cardiol AS Beiser 81 1116 1998 10.1016/S0002-9149(98)00116-7 Beiser AS, Takahashi M, Baker AL, Sundel RP, Newburger JW. A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol 1998;81:1116-20. doi: 10.1016/S0002-9149(98)00116-7 . 

    상세보기

28. J Pediatr M Mori 137 177 2000 10.1067/mpd.2000.107890 Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. J Pediatr 2000;137:177-80. doi: 10.1067/mpd.2000.107890 . 

    상세보기

29. Pediatr Int Y Morikawa 42 464 2000 10.1046/j.1442-200x.2000.01288.x Morikawa Y, Ohashi Y, Harada K, Asai T, Okawa S, Nagashima M, et al. Coronary risks after high dose gamma-globulin in children with Kawasaki disease. Pediatr Int 2000;42:464-9. doi: 10.1046/j.1442-200x.2000.01288.x . 

    상세보기

30. Pediatr Cardiol VE Honkanen 24 122 2003 10.1007/s00246-002-0063-1 Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol 2003;24:122-6. doi: 10.1007/s00246-002-0063-1 . 

    상세보기

31. J Immunol AH Rowley 159 5946 1997 10.4049/jimmunol.159.12.5946 Rowley AH, Eckerley CA, Jack HM, Shulman ST, Baker SC. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol 1997;159:5946-55. 

    상세보기

32. J Infect Dis TJ Brown 184 940 2001 10.1086/323155 Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis 2001;184:940-3. doi: 10.1086/323155 . 

    상세보기

33. Circulation H Senzaki 104 860 2001 10.1161/hc3301.095286 Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Nakano H, Nagasaka H, et al. Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation 2001;104:860-3. doi: 10.1161/hc3301.095286 . 

    상세보기

34. Circulation K Yasukawa 105 766 2002 10.1161/hc0602.103396 Yasukawa K, Terai M, Shulman ST, Toyozaki T, Yajima S, Kohno Y, et al. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation 2002;105:766-9. doi: 10.1161/hc0602.103396 . 

    상세보기

35. Pediatr Res N Maeno 44 596 1998 10.1203/00006450-199810000-00021 Maeno N, Takei S, Masuda K, Akaike H, Matsuo K, Kitajima I, et al. Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr Res 1998;44:596-9. doi: 10.1203/00006450-199810000-00021 . 

    상세보기

36. Scand J Immunol T Asano 51 98 2000 10.1046/j.1365-3083.2000.00650.x Asano T, Ogawa S. Expression of monocyte chemoattractant protein-1 in Kawasaki disease: the anti-inflammatory effect of gamma globulin therapy. Scand J Immunol 2000;51:98-103. doi: 10.1046/j.1365-3083.2000.00650.x . 

    상세보기

37. Pediatr Pulmonol AF Freeman 36 102 2003 10.1002/ppul.10333 Freeman AF, Crawford SE, Finn LS, Lopez-Andreu JA, Ferrando-Monleon S, Perez-Tamarit D, et al. Inflammatory pulmonary nodules in Kawasaki disease. Pediatr Pulmonol 2003;36:102-6. doi: 10.1002/ppul.10333 . 

    상세보기

38. Pediatr Infect Dis J BA Eberhard 14 199 1995 10.1097/00006454-199503000-00006 Eberhard BA, Andersson U, Laxer RM, Rose V, Silverman ED. Evaluation of the cytokine response in Kawasaki disease. Pediatr Infect Dis J 1995;14:199-203. doi: 10.1097/00006454-199503000-00006 . 

    상세보기

39. J Pediatr S Furukawa 124 721 1994 10.1016/S0022-3476(05)81361-7 Furukawa S, Matsubara T, Umezawa Y, Okumura K, Yabuta K. Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. J Pediatr 1994;124:721-5. doi: 10.1016/S0022-3476(05)81361-7 . 

    상세보기

40. J Pediatr CY Lin 121 924 1992 10.1016/S0022-3476(05)80343-9 Lin CY, Lin CC, Hwang B, Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 1992;121:924-6. doi: 10.1016/S0022-3476(05)80343-9 . 

    상세보기